JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 13 No. 12 885-892
© 1972 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Charkes, N. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Charkes, N. D.

Graves' Disease with Functioning Nodules (Marine-Lenhart Syndrome)

N. David Charkes

Temple University School of Medicine, Philadelphia, Pennsylvania

Correspondence: For reprints contact: N. David Charkes, Sec. of Nuclear Medicine, Dept. of Radiology, Temple University School of Medicine, Philadelphia, Pa. 19140.

ABSTRACT

Ten hyperthyroid patients with functioning thyroid nodules were studied in whom Plummer's disease (autonomous nodular goiter) had been excluded by failure of TSH to stimulate suppressed extranodular tissue. The responses of the nodules and the extra nodular tissue to TSH administration were significantly different from those seen in Plummer's disease and were consistent with the responses noted in patients with Graves' disease. It was concluded that these patients had Graves' disease with incidental functioning nodules. In three of six treated patients, the nodules were relatively resistant to 131I therapy, as judged by dose requirement, post-treatment scintigrams, and measurements of nuclear polyploidy. Subtotal thyroidectomy may therefore be the treatment of choice in this syndrome. The frequency of occurrence of incidental functioning nodules was found to be 2.7% of 375 patients with Graves' disease referred to us for testing. In recognition of the investigators who first described this entity biochemically, it is proposed that Graves' disease with incidental functioning nodules be called the Marine Lenhart syndrome.




This article has been cited by other articles:


Home page
RadioGraphicsHome page
C. M. Intenzo, A. E. dePapp, S. Jabbour, J. L. Miller, S. M. Kim, and D. M. Capuzzi
Scintigraphic Manifestations of Thyrotoxicosis
RadioGraphics, July 1, 2003; 23(4): 857 - 869.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1972 by the Society of Nuclear Medicine.